The effects of teriparatide on bone microarchitecture as determined by high resolution magnetic resonance imaging and digital topological analysis.

Trial Profile

The effects of teriparatide on bone microarchitecture as determined by high resolution magnetic resonance imaging and digital topological analysis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2014

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 19 Sep 2011 Results presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR-2011), according to an Eli Lilly media release.
    • 23 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top